pimagedine and thiazolidines

pimagedine has been researched along with thiazolidines in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (18.18)18.2507
2000's9 (81.82)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Izuhara, Y; Jadoul, M; Kurokawa, K; Miyata, T; Saito, A; Ueda, Y; van Ypersele de Strihou, C; Wada, T; Yamada, Y1
Ohta, M1
Asahi, K; Inagi, R; Izuhara, Y; Kurokawa, K; Miyata, T; Saito, A; Ueda, Y; VAN Ypersele DE Strihou, C1
Kado, S; Nagata, N; Wakatsuki, T; Yamamoto, M1
Kawakami, M; Kuroki, M1
Makita, Z; Takeuchi, M; Yamagishi, S1
Uesaka, Y1
Imaizumi, T; Yamagishi, S1
Izuhara, Y; Miyata, T; Yamamoto, M1
Cooper, ME; Coughlan, MT; Forbes, JM1
Choi, JS; Jung, HA; Kang, SS; Kim, YS; Yoon, NY1

Reviews

6 review(s) available for pimagedine and thiazolidines

ArticleYear
[Current advances in the treatment of diabetes mellitus].
    Nihon Ika Daigaku zasshi, 1999, Volume: 66, Issue:3

    Topics: Aldehyde Reductase; Arteriosclerosis; Blood Glucose; Diabetes Mellitus; Enzyme Inhibitors; Guanidines; Humans; Hypoglycemic Agents; Insulin Resistance; Rhodanine; Thiazolidines

1999
[Aminoguanidine and other AGE inhibitors].
    Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 9

    Topics: Amides; Animals; Arteriosclerosis; Cardiovascular Diseases; Cataract; Clinical Trials as Topic; Diabetes Mellitus; Diabetic Nephropathies; Diabetic Retinopathy; Disease Models, Animal; Drug Design; Glycation End Products, Advanced; Guanidines; Humans; Hydrazines; Hypoglycemic Agents; Thiadiazoles; Thiazoles; Thiazolidines

2002
[OPB-9195].
    Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 9

    Topics: Animals; Diabetic Angiopathies; Disease Models, Animal; Drug Design; Glycation End Products, Advanced; Guanidines; Humans; Hypoglycemic Agents; Thiadiazoles; Thiazoles; Thiazolidines

2002
[Prevention and treatment of diabetic neuropathy].
    Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 10

    Topics: Aldehyde Reductase; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Chronic Disease; Diabetic Neuropathies; Enzyme Inhibitors; gamma-Linolenic Acid; Glycation End Products, Advanced; Guanidines; Humans; Insulin; Oxidative Stress; Rhodanine; Thiazolidines

2002
[Progress on the drug therapy for diabetic microangiopathies: AGE inhibitors].
    Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 6

    Topics: Animals; Clinical Trials as Topic; Depression, Chemical; Diabetic Angiopathies; Glycation End Products, Advanced; Guanidines; Humans; Oxidative Stress; Pyridoxamine; Thiadiazoles; Thiamine; Thiazoles; Thiazolidines

2005
Can advanced glycation end product inhibitors modulate more than one pathway to enhance renoprotection in diabetes?
    Annals of the New York Academy of Sciences, 2005, Volume: 1043

    Topics: Animals; Diabetic Nephropathies; Disease Models, Animal; Glycation End Products, Advanced; Guanidines; Humans; Pyridoxamine; Renin-Angiotensin System; Thiadiazoles; Thiazolidines

2005

Other Studies

5 other study(ies) available for pimagedine and thiazolidines

ArticleYear
Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycation end product: carbonyl stress in uremia.
    Journal of the American Society of Nephrology : JASN, 1998, Volume: 9, Issue:12

    Topics: Aged; Aldehydes; Arginine; Carboxylic Acids; Deoxyglucose; Depression, Chemical; Esters; Glycosylation; Guanidines; Humans; Ketones; Lysine; Maillard Reaction; Male; Middle Aged; Molecular Weight; Phenylhydrazines; Renal Dialysis; Thiadiazoles; Thiazolidines; Ultrafiltration; Uremia

1998
Mechanism of the inhibitory effect of OPB-9195 [(+/-)-2-isopropylidenehydrazono-4-oxo-thiazolidin-5-yla cetanilide] on advanced glycation end product and advanced lipoxidation end product formation.
    Journal of the American Society of Nephrology : JASN, 2000, Volume: 11, Issue:9

    Topics: Aldehydes; Arachidonic Acid; Arginine; Deoxyglucose; Dialysis Solutions; Glycation End Products, Advanced; Glyoxal; Guanidines; Lipid Metabolism; Lysine; Malondialdehyde; Oxidation-Reduction; Peritoneal Dialysis; Prodrugs; Pyruvaldehyde; Thiadiazoles; Thiazolidines

2000
Expression of intercellular adhesion molecule-1 induced by high glucose concentrations in human aortic endothelial cells.
    Life sciences, 2001, Jan-05, Volume: 68, Issue:7

    Topics: Aldehyde Reductase; Aorta; Collagen; Endothelium, Vascular; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Glucose; Guanidines; Humans; Intercellular Adhesion Molecule-1; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; Rhodanine; RNA, Messenger; Staurosporine; Thiazolidines

2001
From molecular footprints of disease to new therapeutic interventions in diabetic nephropathy.
    Annals of the New York Academy of Sciences, 2005, Volume: 1043

    Topics: Animals; Antioxidants; Biomarkers; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glycation End Products, Advanced; Guanidines; Humans; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Thiadiazoles; Thiazolidines

2005
Inhibitory activities of prenylated flavonoids from Sophora flavescens against aldose reductase and generation of advanced glycation endproducts.
    The Journal of pharmacy and pharmacology, 2008, Volume: 60, Issue:9

    Topics: Aldehyde Reductase; Animals; Chalcones; Flavones; Flavonoids; Glycation End Products, Advanced; Guanidines; Humans; Inhibitory Concentration 50; Medicine, Traditional; Plant Extracts; Quercetin; Rats; Rats, Sprague-Dawley; Rhodanine; Sophora; Thiazolidines

2008